🔗 Visit the ClinicalTrials.gov page for NCT04388631
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. | Cell | 2020 | 3.29 |
| 2 | The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis. | Endocrinology | 2004 | 0.94 |
| 3 | Orchitis: a complication of severe acute respiratory syndrome (SARS). | Biol Reprod | 2005 | 0.76 |
| 4 | Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury. | J Sex Med | 2014 | 0.75 |